DESMA PHARMA Group manufactures and markets proprietary, branded, ethical and OTC products in more than 40 countries worldwide and we constantly increase our business by acquisition of mature brands. More
OrPha Swiss is looking of in - and out-licensing opportunities in the field of anaesthesia, intensive care, neurology, pulmonary hypertension and addiction medicine More
Inven2 AS identifies, protects and commercialises inventions and discoveries of the University of Oslo, Oslo University Hospital and other health enterprises in the south-east of Norway. More
INVAR is a privately-owned, pharmaceutical company specializing on the commercialization of innovative medicines in the local market acquired through exclusive in-licensing & distribution agreements. More
PBL manages and invests in the protection and development of emerging technology across the life sciences, sourcing innovation from public research sources worldwide More